L-DEP as an Initial Treatment for EBV-HLH

Clinical trial NCT02912702 · UNKNOWN

Trial details

NCT number: NCT02912702
Sponsor: Beijing Friendship Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophagocytic Lymphohistiocytosis

Start date: 2016-09-01
Primary completion: 2018-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.